| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.5B | $14.7B | $15.4B | $14.1B | $13.7B | $12.7B | $16.5B | $17.4B |
| Cost of Revenue | $13.6B | $13.8B | $14.4B | $13.3B | $12.9B | $12.1B | $15.7B | $16.5B |
| Gross Profit | $1.0B | $0.9B | $1.0B | $0.8B | $0.8B | $0.6B | $0.8B | $0.9B |
| R&D Expense | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| SG&A Expense | $0.5B | $0.5B | $0.6B | $0.6B | $0.5B | $0.6B | $0.7B | $0.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.3B | $0.0B | $0.2B | $-0.1B | $1.1B | $-0.5B | $-0.5B | $-1.7B |
| EPS (Basic) | $-3.39 | $0.20 | $2.17 | $-1.27 | $11.76 | $-5.83 | $-5.25 | $-18.06 |
| EPS (Diluted) | $-3.39 | $0.20 | $2.15 | $-1.27 | $11.58 | $-5.83 | $-5.25 | $-18.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $9.4B | $9.4B | $9.2B | $10.8B | $10.3B | $10.3B | $10.9B |
| Current Assets | $4.1B | $4.1B | $4.3B | $4.2B | $5.1B | $4.5B | $4.1B | $4.3B |
| Cash & Equivalents | — | — | — | — | — | — | $0.9B | $0.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.7B | $3.7B | $3.7B | $3.5B | $3.5B | $3.8B | $3.8B | $4.2B |
| Stockholders' Equity | $1.8B | $2.1B | $2.2B | $2.1B | $2.4B | $1.2B | $1.8B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.7B | $0.3B | $0.3B | $0.2B | $0.3B | $0.7B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.2B | $0.5B | $0.3B | $0.2B | $-0.4B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.5B | $-0.3B | $-1.3B | $-0.8B | $0.4B | $0.3B | $-0.2B |